Johnson DH - Search Results

1

Phase II study of irinotecan plus cisplatin in patients with advanced non-small-cell lung cancer.

DeVore RF, Johnson DH, Crawford J, Garst J, Dimery IW, Eckardt J, Eckhardt SG, Elfring GL, Schaaf LJ, Hanover CK, Miller LL. DeVore RF, et al. Among authors: johnson dh. J Clin Oncol. 1999 Sep;17(9):2710-20. doi: 10.1200/JCO.1999.17.9.2710. J Clin Oncol. 1999. PMID: 10561345 Clinical Trial.

2

A phase II trial of cisplatin and prolonged administration of oral etoposide in extensive-stage small cell lung cancer.

Murphy PB, Hainsworth JD, Greco FA, Hande KR, DeVore RF, Johnson DH. Murphy PB, et al. Among authors: johnson dh. Cancer. 1992 Jan 15;69(2):370-5. doi: 10.1002/1097-0142(19920115)69:2<370::aid-cncr2820690217>3.0.co;2-e. Cancer. 1992. PMID: 1309432 Clinical Trial.

3

Carboplatin plus oral etoposide in the management of unresectable non-small cell lung cancer. Preliminary results of a Vanderbilt trial.

Johnson DH, Hainsworth JD, DeVore R, Hande KR, Greco FA. Johnson DH, et al. Oncology. 1992;49 Suppl 1:57-61; discussion 61-2. doi: 10.1159/000227112. Oncology. 1992. PMID: 1323813 Clinical Trial.

4

Carboplatin plus oral etoposide in the management of advanced, non-small cell lung cancer: preliminary results of a Vanderbilt trial.

Johnson DH, DeVore R, Greco FA, Walls J, Thomas M, Hande KR, Hainsworth JD. Johnson DH, et al. Semin Oncol. 1992 Feb;19(1 Suppl 2):50-6. Semin Oncol. 1992. PMID: 1329223 Clinical Trial.

5

Paclitaxel plus carboplatin for advanced lung cancer: preliminary results of a Vanderbilt University phase II trial--LUN-46.

Johnson DH, Paul DM, Hande KR, DeVore RF 3rd. Johnson DH, et al. Semin Oncol. 1995 Aug;22(4 Suppl 9):30-3. Semin Oncol. 1995. PMID: 7644925 Clinical Trial.

6

Combination chemotherapy with or without thoracic radiotherapy in limited-stage small-cell lung cancer: a randomized trial of the Southeastern Cancer Study Group.

Johnson DH, Bass D, Einhorn LH, Crawford J, Perez CA, Bartolucci A, Omura GA, Greco FA. Johnson DH, et al. J Clin Oncol. 1993 Jul;11(7):1223-9. doi: 10.1200/JCO.1993.11.7.1223. J Clin Oncol. 1993. PMID: 8391064 Clinical Trial.

7

Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a phase II trial.

Johnson DH, Paul DM, Hande KR, Shyr Y, Blanke C, Murphy B, Lewis M, De Vore RF 3rd. Johnson DH, et al. J Clin Oncol. 1996 Jul;14(7):2054-60. doi: 10.1200/JCO.1996.14.7.2054. J Clin Oncol. 1996. PMID: 8683236 Clinical Trial.

8

Paclitaxel plus carboplatin in the treatment of patients with advanced lung cancer: a Vanderbilt University Cancer Center phase II trial (LUN-46).

Johnson DH, Paul DM, Hande KR, DeVore R. Johnson DH, et al. Semin Oncol. 1996 Dec;23(6 Suppl 16):42-6. Semin Oncol. 1996. PMID: 9007120 Clinical Trial.

9

Preliminary analysis of a phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small cell lung cancer.

Choy H, DeVore RF 3rd, Hande KR, Porter LL, Rosenblatt P, Yunus F, Schlabach L, Smith C, Shyr Y, LaPorte K, Johnson DH. Choy H, et al. Among authors: johnson dh. Semin Oncol. 1997 Aug;24(4 Suppl 12):S12-21-S12-26. Semin Oncol. 1997. PMID: 9331115 Clinical Trial.

10

Paclitaxel by either 1-hour or 24-hour infusion in combination with carboplatin in advanced non-small cell lung cancer: preliminary results comparing sequential phase II trials.

DeVore RF 3rd, Jagasia M, Johnson DH. DeVore RF 3rd, et al. Among authors: johnson dh. Semin Oncol. 1997 Aug;24(4 Suppl 12):S12-27-S12-29. Semin Oncol. 1997. PMID: 9331116 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

706 results

Search Page

Filters